← Open Payments lookup

SAMUEL MACHUCA: Open Payments

NPI 1801597372 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$543 in 15 payments from 10 companies in 2025. Trend: 2023 $57 · 2024 $141 · 2025 $543

Food & beverage: $543
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$154
GENZYME CORPORATION1$122
GlaxoSmithKline, LLC.3$78
Takeda Pharmaceuticals U.S.A., Inc.2$45
Verona Pharma, Inc.2$40
Merck Sharp & Dohme LLC1$35
Actelion Pharmaceuticals US, Inc.1$20
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
Grifols USA, LLC1$17
Viatris Specialty LLC1$15

Products named: BREZTRI, DUPIXENT, NUCALA, Ohtuvayre, PREVYMIS, FASENRA, ARALAST, OPSYNVI.

Industry payments across TX — which companies pay providers there.